Voriconazole study.
Completed
- Conditions
- CF patients with Aspergillus infection.
- Registration Number
- NL-OMON28850
- Lead Sponsor
- erasmusmc sophia
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Confirmed diagnosis of CF (documented by positive sweat test and/or by positive rectal current measurement, and/or genotype consistent with CF two positive CF mutations, accompanied with two or more clinical features consistent with the CF phenotype);
2. At least three positive cultures for Aspergillus in the two years prior to the study;
Exclusion Criteria
1. Allergy to voriconazole;
2. Use of drugs contraindicating use of;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Is treatment with voriconazole in cf patients with a chronic Aspergillus infection effective?
- Secondary Outcome Measures
Name Time Method